LY2608204( LY-2608204 | LY 2608204 | LY2608204 )

Catalog No. M17209 CAS No. 1234703-40-2

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

LY2608204
Note

Research use only, not for human use.
Brief Description

LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.
Description

LY-2608204 is an activator of glucokinase (GK) with an EC50 value of 42 nM. LY2608204 decreases plasma glucose in a dose-dependent manner at both fasted and postprandial glucose levels. In 2010, LY-2608204 was entered clinical trials in Patients With Type 2 Diabetes.
In Vitro

——
In Vivo

——
Synonyms

LY-2608204 | LY 2608204 | LY2608204
Pathway

Neuroscience
Target

GluR
Recptor

glucokinase
Research Area

Metabolic Disease
Indication

——

CAS Number

1234703-40-2
Formula Weight

559.81
Molecular Formula

C28H37N3O3S3
Purity

>98% (HPLC)
Solubility

DMSO : ≥ 100 mg/mL. 178.63 mM
SMILES

C1CCC(CC1)[C@@H]1C[C@]1(C(=O)Nc1ncc(s1)SCCN1CCCC1)c1ccc(cc1)S(=O)(=O)C1CC1
Chemical Name

(1R,2S)-2-cyclohexyl-1-(4-cyclopropylsulfonylphenyl)-N-[5-(2-pyrrolidin-1-ylethylsulfanyl)-1,3-thiazol-2-yl]cyclopropane-1-carboxamide